维普中文期刊产品整合服务
1684篇 您的检索式:作者名="PhilippeE"
    题名 作者 年代 出处 被引量
1International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas显示文摘Masao Tanaka Carlos Fernández-del Castillo Volkan Adsay Suresh Chari Massimo Falconi Jin-Young Jang Wataru Kimura Philippe Levy Martha Bishop Pitman C. Max Schmidt Michio Shimizu Christopher L. Wolfgang Koji Yamaguchi Kenji Yamao 2012Pancreatology2012,,3:13
2Epidemiology and Natural History of Inflammatory Bowel Diseases显示文摘Jacques Cosnes Corinne Gower–Rousseau Philippe Seksik Antoine Cortot 2011Gastroenterology2011,,6:11
3Gastroenteropancreatic neuroendocrine tumours显示文摘Irvin M Modlin Kjell Oberg Daniel C Chung Robert T Jensen Wouter W de Herder Rajesh V Thakker Martyn Caplin Gianfranco Delle Fave Greg A Kaltsas Eric P Krenning Steven F Moss Ola Nilsson Guido Rindi Ramon Salazar Philippe Ruszniewski Anders Sundin 2008Lancet Oncology2008,,1:8
4Growing locations: Industry location in a model of endogenous growth显示文摘Philippe Martin Gianmarco I.P. Ottaviano 1999European Economic Review1999,,2:7
5Determinant-Based Classification of Acute Pancreatitis Severity: An International Multidisciplinary Consultation显示文摘E. Patchen Dellinger Christopher E. Forsmark Peter Layer Philippe Lévy Enrique Maraví-Poma Maxim S. Petrov Tooru Shimosegawa Ajith K. Siriwardena Generoso Uomo David C. Whitcomb John A. Windsor 2012Annals of Surgery2012,,6:7
6基于局部因素和全身因素对急性胰腺炎严重程度的新分级——概要与解读显示文摘急性胰腺炎严重程度的准确分级对于临床实践和研究十分重要。在临床实践中,准确的分型有助于正确地评估疾病的严重程度,监测疾病的发展,制定治疗策略。而临床研究中,准确的分型对于患者的正确入组、实验结果的有效性都有很大影响。一个多世纪以来,急性胰腺炎的严重程度被简单地分为轻型和重型,而且对于轻型和重型的定义尚未统一。近年来,研究发现重型胰腺炎又有不同的亚组,而不同亚组患者的预后有很大差异,轻型和重型二分法的局限性慢慢显现。李维勤 张璐瑶 黎介寿 E.Patchen Dellinger Christopher E.Forsmark Peter Layer Philippe L'evy Enrique Maravi-Poma Maxim S.Petrov 2014中华外科杂志2014,52,5:6
7Effects of KRAS, BRAF, NRAS , and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis显示文摘Wendy De Roock Bart Claes David Bernasconi Jef De Schutter Bart Biesmans George Fountzilas Konstantine T Kalogeras Vassiliki Kotoula Demetris Papamichael Pierre Laurent-Puig Frédérique Penault-Llorca Philippe Rougier Bruno Vincenzi Daniele Santini Giusepp 2010Lancet Oncology2010,,8:6
8Epidemiology and Diagnosis of H elicobacter pylori Infection显示文摘Ante Tonkic Marija Tonkic Philippe Lehours Francis Mégraud 2012Helicobacter2012,,:6
9Bank income structure and risk: An empirical analysis of European banks显示文摘Laetitia Lepetit Emmanuelle Nys Philippe Rous Amine Tarazi 2007Journal of Banking and Finance2007,,8:5
10Diagnosis and Epidemiology of H elicobacter pylori Infection显示文摘Xavier Calvet María‐José Ramírez Lázaro Philippe Lehours Francis Mégraud 2013Helicobacter2013,,:5
11Hepatitis B virus genotypes and extrahepatic manifestations显示文摘Patrice Cacoub David Saadoun Marc Bourlière Hacene Khiri Agnes Martineau Yves Benhamou Marina Varastet Stanislas Pol Vincent Thibault Michel Rotily Philippe Halfon 2005Journal of Hepatology2005,,5:5
12Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials显示文摘Carsten Bokemeyer Eric Van Cutsem Philippe Rougier Fortunato Ciardiello Steffen Heeger Michael Schlichting Ilhan Celik Claus-Henning K?hne 2012European Journal of Cancer2012,,10:5
13Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial显示文摘Geert D’Haens Filip Baert Gert van Assche Philip Caenepeel Philippe Vergauwe Hans Tuynman Martine De Vos Sander van Deventer Larry Stitt Allan Donner Severine Vermeire Frank J Van De Mierop Jean-Charles R Coche Janneke van der Woude Thomas Ochsenkühn Ad A 2008The Lancet2008,,9613:5
14Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial显示文摘Hansjochen Wilke Kei Muro Eric Van Cutsem Sang-Cheul Oh Gy?rgy Bodoky Yasuhiro Shimada Shuichi Hironaka Naotoshi Sugimoto Oleg Lipatov Tae-You Kim David Cunningham Philippe Rougier Yoshito Komatsu Jaffer Ajani Michael Emig Roberto Carlesi David Ferry Kuma 2014Lancet Oncology2014,,11:4
15The natural history of Ebola virus in Africa显示文摘Xavier Pourrut Brice Kumulungui Tatiana Wittmann Ghislain Moussavou André Délicat Philippe Yaba Dieudonné Nkoghe Jean-Paul Gonzalez Eric Maurice Leroy 2005Microbes and Infection2005,,7:4
16Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease显示文摘Vlad Ratziu Frédéric Charlotte Agnès Heurtier Sophie Gombert Philippe Giral Eric Bruckert André Grimaldi Frédérique Capron Thierry Poynard 2005Gastroenterology2005,,7:4
17Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer显示文摘Philippe Rougier Hanno Riess Robert Manges Petr Karasek Yves Humblet Carlo Barone Armando Santoro Sylvie Assadourian Laurence Hatteville Philip A. Philip 2013European Journal of Cancer2013,,12:4
18骨骼肌组织对鸡胚背根节细胞GABA表达的影响显示文摘采用在体和离体实验及随后的免疫组织化学方法,研究了周围靶组织对鸡背根节(DRG)内GABA细胞发育的影响。在胚胎6d行鸡胚单侧右后肢切除后12d,切除侧后肢缺如,其DRG明显小于对照侧,其细胞数量也明显少于对照侧。实验侧的DRG细胞均呈GABA阴性,而对照侧有7.0%的感觉神经细胞为GABA阳性。在L4~S1脊髓边缘切断右侧脊神经根后12d,DRG的形态无特殊异常,GA-BA免疫反应细胞的出现率与对照侧相同。取自胚胎6d的鸡胚DRG细胞培养12d后的GABA免疫反应为阴性。然而,当同样胚龄的DRG细胞与骨骼肌细胞共同培养12d后,有部分DRG细胞呈GABA阳性反应,其神经突起与骨骼肌细胞相连。这些结果表明:鸡胚DRG细胞GABA的表达是依赖其周围靶组织——骨骼肌的存在,与其中枢靶组织无关。周长满 陈彪 王雪岷 PhilippeE 1997解剖学报1997,28,4:4
19The determinants of venture capital funding: evidence across countries显示文摘Leslie A. Jeng Philippe C. Wells 2000Journal of Corporate Finance2000,,3:4
20Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors显示文摘Martyn E. Caplin Marianne Pavel Jaros?aw B. ?wik?a Alexandria T. Phan Markus Raderer Eva Sedlá?ková Guillaume Cadiot Edward M. Wolin Jaume Capdevila Lucy Wall Guido Rindi Alison Langley Séverine Martinez Jo?lle Blumberg Philippe Ruszniewski 2014The New England Journal of Medicine2014,,:3
返回顶部 每页显示:
共85页 首页 上一页 第1页 下一页 末页 /85 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费